FECK
发表于 2025-3-26 23:03:00
http://reply.papertrans.cn/59/5833/583297/583297_31.png
天气
发表于 2025-3-27 03:23:41
r the use in parasitology (Heřmánek and Prokopič 1989). In this study we investigated the possibility of thymic preparations to influence the resistance to model parasite infections (2 helminthoses — cysticercosis and ascaridosis and 2 protozooses — coccidiosis and cryptosporidiosis) in intact and i
挥舞
发表于 2025-3-27 07:59:59
http://reply.papertrans.cn/59/5833/583297/583297_33.png
Volatile-Oils
发表于 2025-3-27 12:38:34
Betina Hollsteintoxic side effects (Schumann and others, 1989). Reduction of toxicity may be accomplished by encapsulation of MTPPE in liposomes, which are taken up preferably by the cells of the MPS. The question is whether liposome-encapsulated MTPPE (LE-MTPPE) retains its activity. LE-MTPPE has proven to be bene
放弃
发表于 2025-3-27 16:16:28
Jan Marbachsing nodal regions that may not be irradiated with more conformal techniques. Traditional forms of radiation in particular pose challenges for combination trials with immunotherapy. This chapter explores these issues in more detail and provides insights as to how radiation therapy can be optimized t
ADORE
发表于 2025-3-27 18:04:11
Frank Lettke auditory complications can lead to speech recognition deficits and sensorineural hearing loss. Ocular toxicities are among the most common adverse events resulting from the use of these agents. The majority of ocular immune-related adverse events (irAEs) are mild, low-grade, non-sight threatening,
jaundiced
发表于 2025-3-28 01:25:04
http://reply.papertrans.cn/59/5833/583297/583297_37.png
纹章
发表于 2025-3-28 02:46:10
http://reply.papertrans.cn/59/5833/583297/583297_38.png
Frequency
发表于 2025-3-28 08:14:48
Heinz Blaumeiser,Thomas Klie development to predict response to immunotherapy and risk of toxicity. This book chapter is a comprehensive review of immunotherapeutic approaches, both approved and investigational, for the treatment of renal cell carcinoma, urothelial carcinoma, and prostate cancer.
过多
发表于 2025-3-28 11:37:24
http://reply.papertrans.cn/59/5833/583297/583297_40.png